TP53 status and gene amplification in human colorectal carcinomas

被引:6
|
作者
Soulié, P
Fourme, E
Hamelin, R
Asselain, B
Salmon, RJ
Dutrillaux, B
Muleris, M
机构
[1] Inst Curie, CNRS UMR147, F-75248 Paris 05, France
[2] Inst Curie, Unite Biostat, F-75248 Paris 05, France
[3] Inst Curie, Dept Surg, F-75248 Paris 05, France
[4] INSERM U434 CEPH, Paris, France
关键词
D O I
10.1016/S0165-4608(99)00073-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene amplification is one of the characteristics of cancer cells. In vitro studies suggested that alterations of the TP53 gene might be responsible for gene amplification. We have examined the presence of TP53 mutations and looked for cytogenetic evidence of gene amplification in a series of 79 primary colorectal carcinomas. Of her parameters such as the pattern of cytogenetic alterations, microsatellite instability tumor site, and histological staging were of so considered. A multiparametric study supported by statistical analyses suggests the existence of two major path was of colorectal carcinogenesis. No relationships could be established between the presence of TP53 alterations and gene amplification. (C) 1999 Elsevier Science, Inc. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [1] The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
    Langerod, A
    Bukholm, IRK
    Bregård, A
    Lonning, PE
    Andersen, TI
    Rognum, TO
    Meling, GI
    Lothe, RA
    Borresen-Dale, AL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1684 - 1688
  • [2] Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas
    Plisiecka-Halasa, Joanna
    Dansonka-Mieszkowska, Agnieszka
    Kraszewska, Ewa
    Danska-Bidzinska, Anna
    Kupryjanczyk, Jolanta
    ANTICANCER RESEARCH, 2008, 28 (2A) : 989 - 996
  • [3] The Relationship between TP53 Gene Status and Carboxylesterase 2 Expression in Human Colorectal Cancer
    Ishimine, Momoko
    Lee, Hyeon-Cheol
    Nakaoka, Hirofumi
    Orita, Hajime
    Kobayashi, Toshiyuki
    Mizuguchi, Konomi
    Endo, Mikumi
    Inoue, Ituro
    Sato, Koichi
    Yokomizo, Takehiko
    DISEASE MARKERS, 2018, 2018
  • [4] MDM2 GENE AMPLIFICATION AND TRANSCRIPT LEVELS IN HUMAN SARCOMAS - RELATIONSHIP TO TP53 GENE STATUS
    FLORENES, VA
    MAELANDSMO, GM
    FORUS, A
    ANDREASSEN, A
    MYKLEBOST, O
    FODSTAD, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1297 - 1302
  • [5] Somatic Variant Profiles of TP53 Mutant Colorectal Carcinomas
    Olofson, Andrea
    He, John
    Peterson, Jason D.
    Deharvengt, Sophie J.
    de Abreu, Francine B.
    Liu, Xiaoying
    Tsongalis, Gregory J.
    LABORATORY INVESTIGATION, 2017, 97 : 192A - 192A
  • [6] Somatic Variant Profiles of TP53 Mutant Colorectal Carcinomas
    Olofson, Andrea
    He, John
    Peterson, Jason D.
    Deharvengt, Sophie J.
    de Abreu, Francine B.
    Liu, Xiaoying
    Tsongalis, Gregoty J.
    MODERN PATHOLOGY, 2017, 30 : 192A - 192A
  • [7] SCREENING FOR TP53 GENE-MUTATIONS IN ESOPHAGEAL CARCINOMAS
    AUDREZET, MP
    ROBASZKIEWICZ, M
    MERCIER, B
    NOUSBAUM, JB
    GUILLERMIT, H
    GOUEROU, H
    FEREC, C
    GASTROENTEROLOGY, 1993, 104 (04) : A386 - A386
  • [8] Novel Mutations of the Suppressor Gene PTEN in Colorectal Carcinomas Stratified by Microsatellite Instability- and TP53 Mutation- Status
    Danielsen, Stine A.
    Lind, Guro E.
    Bjornslett, Merete
    Meling, Gunn I.
    Rognum, Torleiv O.
    Heim, Sverre
    Lothe, Ragnhild A.
    HUMAN MUTATION, 2008, 29 (11) : E252 - E262
  • [9] ALTERATIONS OF THE TP53 GENE IN HUMAN GLIOMAS
    RASHEED, BKA
    MCLENDON, RE
    HERNDON, JE
    FRIEDMAN, HS
    FRIEDMAN, AH
    BIGNER, DD
    BIGNER, SH
    CANCER RESEARCH, 1994, 54 (05) : 1324 - 1330
  • [10] TP53: a key gene in human cancer
    Guimaraes, DP
    Hainaut, P
    BIOCHIMIE, 2002, 84 (01) : 83 - 93